The Standard of Care for Treating Head Lice

At a time when decades-old OTC formulations are no longer effective due to head lice resistance1, 3 out of 5 pediatricians prescribe Spinosad Topical Suspension 0.9%2.
Learn more

Spinosad Packaging

Evolve Your Practice with Spinosad Topical Suspension 0.9%

Today, every practice needs a solution that effectively treats resistant head lice, while assisting you with changing protocols and patient demands:

No known resistance to the compound, spinosad, in head lice<sup>3</sup>

No known resistance to the compound, spinosad, in head lice3

Find Spinosad Topical Suspension 0.9% Near You

Find Spinosad Topical Suspension 0.9% Near You

Formulary & Pharmacy Finders help you quickly confirm insurance coverage and pharmacies with product availability.
Need Local Support?

Need Local Support?

Request a virtual or in-person visit with a ParaPROfessional™ to answer product and treatment questions, or help with practice tools.
Important Safety Information

Indication
Spinosad Topical Suspension 0.9% is a pediculicide indicated for the topical treatment of head lice infestations in patients six (6) months of age and older.

Adjunctive Measures
Spinosad Topical Suspension 0.9% should be used in the context of an overall lice management program:
• Wash (in hot water) or dry clean all recently worn clothing, hats, used bedding and towels
• Wash personal care items such as combs, brushes, and hair clips in hot water
• A fine-toothed comb or special nit comb may be used to remove dead lice and nits.

Important Safety Information
Spinosad Topical Suspension 0.9% contains benzyl alcohol and is not recommended for use in neonates and infants below the age of 6 months. Systemic exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants when administered intravenously. Most common adverse events were: application site redness (3%), eye redness (2%) and application site irritation (1%).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Reference(s)
  1. Gellatly KJ, Krim S,Palenchar DJ, et al. Expansion of the knockdown resistance frequency map for human head lice (phthiraptera: pediculidae) in the United States using quantitative sequencing. Journal of Medical Entomology, 2016:1-7
  2. IQVIA: May 5, 2020
  3. Spinosad Technical Bulletin Dow AgroSciences LLC (Now Corteva agriscience), Form No. Y45-000-001 (01/01) CBK.

SPN-RRW1-001

Important Safety Information

Indication
Spinosad Topical Suspension 0.9% is a pediculicide indicated for the topical treatment of head lice infestations in patients six (6) months of age and older.

Adjunctive Measures
Spinosad Topical Suspension 0.9% should be used in the context of an overall lice management program:
• Wash (in hot water) or dry clean all recently worn clothing, hats, used bedding and towels
• Wash personal care items such as combs, brushes, and hair clips in hot water
• A fine-toothed comb or special nit comb may be used to remove dead lice and nits.

Important Safety Information
Spinosad Topical Suspension 0.9% contains benzyl alcohol and is not recommended for use in neonates and infants below the age of 6 months. Systemic exposure to benzyl alcohol has been associated with serious adverse reactions and death in neonates and low birth-weight infants when administered intravenously. Most common adverse events were: application site redness (3%), eye redness (2%) and application site irritation (1%).

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.